サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1316504

バイオ医薬品サードパーティロジスティクス市場：サプライチェーン別（コールドチェーン、非コールドチェーン）、サービスタイプ別（輸送、倉庫・保管）-世界予測2023-2030年

Biopharmaceutical Third Party Logistics Market by Supply Chain (Cold Chain, Non-Cold Chain), Service Type (Transportation, Warehousing & Storage) - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 198 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
バイオ医薬品サードパーティロジスティクス市場：サプライチェーン別（コールドチェーン、非コールドチェーン）、サービスタイプ別（輸送、倉庫・保管）-世界予測2023-2030年
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 198 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオ医薬品サードパーティロジスティクスの世界市場は、2023年に1,070億8,000万米ドル、CAGR14.13%で大幅な成長が予測され、2030年には2,713億2,000万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のバイオ医薬品サードパーティロジスティクス市場を評価するために不可欠です。事業戦略や製品満足度などの主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.バイオ医薬品サードパーティロジスティクスの世界市場規模および予測は？

2.予測期間中、世界のバイオ医薬品サードパーティロジスティクス市場を形成するCOVID-19の阻害要因と影響は？

3.バイオ医薬品サードパーティロジスティクスの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.バイオ医薬品サードパーティロジスティクスの世界市場における競争戦略は？

5.バイオ医薬品サードパーティロジスティクスの世界市場における技術動向と規制の枠組みは？

6.バイオ医薬品サードパーティロジスティクスの世界市場における主要ベンダーの市場シェアは？

7.バイオ医薬品サードパーティロジスティクスの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 製薬およびバイオ医薬品産業の研究開発（R&D）支出の増加
      • 生物製剤を輸送するための温度管理された物流サービスのニーズの高まり
      • さまざまな医療機関による物流のアウトソーシングの新たな傾向
    • 抑制要因
      • 医薬品開発および創薬手続きにかかる高額なコスト
    • 機会
      • バイオ医薬品サードパーティロジスティクスソリューションにおける技術の進歩の進展
      • 急速に高まるバイオシミラー医薬品のニーズ
    • 課題
      • 国際物流手続きに関する厳格な政府の規則と規制
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 バイオ医薬品サードパーティロジスティクス市場サプライチェーン別

  • コールドチェーン
  • 非コールドチェーン

第7章 バイオ医薬品サードパーティロジスティクス市場：サービスタイプ別

  • 交通機関
    • 航空貨物
    • 陸路
    • 海上輸送貨物
  • 倉庫と保管

第8章 南北アメリカのバイオ医薬品サードパーティロジスティクス市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のバイオ医薬品サードパーティロジスティクス市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのバイオ医薬品サードパーティロジスティクス市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第12章 掲載企業一覧

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2022 VS 2030 (%)
  • FIGURE 5. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2022 VS 2030 (%)
  • FIGURE 6. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET DYNAMICS
  • FIGURE 8. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 5. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COLD CHAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY NON-COLD CHAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 9. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY OVERLAND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING & STORAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 41. CHINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 42. CHINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 44. INDIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 45. INDIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 47. INDONESIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 48. INDONESIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 50. JAPAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 51. JAPAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 53. MALAYSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 54. MALAYSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 56. PHILIPPINES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 57. PHILIPPINES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 59. SINGAPORE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 60. SINGAPORE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 62. SOUTH KOREA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 63. SOUTH KOREA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 65. TAIWAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 66. TAIWAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 68. THAILAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 69. THAILAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 71. VIETNAM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 72. VIETNAM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 78. DENMARK BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 79. DENMARK BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 81. EGYPT BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 82. EGYPT BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 84. FINLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 85. FINLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 87. FRANCE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 88. FRANCE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 90. GERMANY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 91. GERMANY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 93. ISRAEL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 94. ISRAEL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 96. ITALY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 97. ITALY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 99. NETHERLANDS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 100. NETHERLANDS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 102. NIGERIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 103. NIGERIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 105. NORWAY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 106. NORWAY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 108. POLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 109. POLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 111. QATAR BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 112. QATAR BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 114. RUSSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 115. RUSSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 117. SAUDI ARABIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 118. SAUDI ARABIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 120. SOUTH AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 123. SPAIN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 124. SPAIN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 126. SWEDEN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 127. SWEDEN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 129. SWITZERLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 130. SWITZERLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 132. TURKEY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 133. TURKEY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED ARAB EMIRATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED ARAB EMIRATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED KINGDOM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED KINGDOM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
  • TABLE 141. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 142. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 143. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET LICENSE & PRICING
目次
Product Code: MRR-563BF1FCF81A

The Global Biopharmaceutical Third Party Logistics Market is forecasted to grow significantly, with a projected USD 107.08 billion in 2023 at a CAGR of 14.13% and expected to reach a staggering USD 271.32 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Biopharmaceutical Third Party Logistics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Biopharmaceutical Third Party Logistics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Supply Chain, market is studied across Cold Chain and Non-Cold Chain. The Cold Chain is projected to witness significant market share during forecast period.

Based on Service Type, market is studied across Transportation and Warehousing & Storage. The Transportation is further studied across Air Freight, Overland, and Sea Freight. The Transportation is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Biopharmaceutical Third Party Logistics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biopharmaceutical Third Party Logistics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biopharmaceutical Third Party Logistics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biopharmaceutical Third Party Logistics Market?

4. What is the competitive strategic window for opportunities in the Global Biopharmaceutical Third Party Logistics Market?

5. What are the technology trends and regulatory frameworks in the Global Biopharmaceutical Third Party Logistics Market?

6. What is the market share of the leading vendors in the Global Biopharmaceutical Third Party Logistics Market?

7. What modes and strategic moves are considered suitable for entering the Global Biopharmaceutical Third Party Logistics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Biopharmaceutical Third Party Logistics Market, by Supply Chain, 2022 vs 2030
  • 4.3. Biopharmaceutical Third Party Logistics Market, by Service Type, 2022 vs 2030
  • 4.4. Biopharmaceutical Third Party Logistics Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing research and development (R&D) expenditure of pharmaceutical and biopharmaceutical industry
      • 5.1.1.2. Rising need for temperature-controlled logistic services to transport biologics
      • 5.1.1.3. Emerging trend of outsourcing logistics by various medical organizations
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of drug development and drug discovery procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing technological advancements in biopharmaceutical third party logistics solutions
      • 5.1.3.2. Rapidly growing need for the biosimilar medicines
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent governmental rules and regulations for international logistics procedures
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Biopharmaceutical Third Party Logistics Market, by Supply Chain

  • 6.1. Introduction
  • 6.2. Cold Chain
  • 6.3. Non-Cold Chain

7. Biopharmaceutical Third Party Logistics Market, by Service Type

  • 7.1. Introduction
  • 7.2. Transportation
    • 7.2.1. Air Freight
    • 7.2.2. Overland
    • 7.2.3. Sea Freight
  • 7.3. Warehousing & Storage

8. Americas Biopharmaceutical Third Party Logistics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biopharmaceutical Third Party Logistics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biopharmaceutical Third Party Logistics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing